New hope for liver cancer patients who run out of options
Disease control
Ongoing
This study is testing the drug cabozantinib for people with advanced liver cancer (hepatocellular carcinoma) whose tumors have continued to grow despite treatment with immunotherapy drugs. The goal is to see if cabozantinib can help control the cancer, slow its progression, and e…
Phase: PHASE2 • Sponsor: Stephen Chan Lam • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC